Inga Winge
About
Inga Winge is from Oslo, Oslo, Norway. Inga works in the following industries: "Research Services". Inga is currently Discovery Project Leader at Nykode Therapeutics, located in Oslo, Norway. In Inga's previous role as a Senior Scientist at Vaccibody AS, Inga worked in Oslo, Norway until Oct 2021. Prior to joining Vaccibody AS, Inga was a Senior Lab Manager, Peter Liljeström Lab at Karolinska Institutet and held the position of Senior Lab Manager, Peter Liljeström Lab at Stockholm County, Sweden. Prior to that, Inga was a Senior Scientist, Karin Loré Lab at Karolinska Institutet, based in Stockholm, Stockholm County, Sweden from Nov 2019 to Aug 2021. Inga started working as Postdoctoral Researcher at Karolinska institutet in Stockholm, Sweden in Jan 2016. From Jul 2015 to Dec 2015, Inga was Research Assistant at Institute of Biochemistry and Biophysics PAS, based in Warsaw, Masovian District, Poland. Prior to that, Inga was a Graduate Research Intern at Université Grenoble Alpes, based in Grenoble Area, France from Oct 2014 to Oct 2015. Inga started working as Graduate Research Intern at CODA / CERVA in Brussels Area, Belgium in Nov 2013.
Inga Winge's email is available on Finalscout.com free of charge. This database has a wealth of information on over half a billion business professionals and two hundred million companies.
Inga Winge's current jobs
Inga Winge's past jobs
• leading and conducting research focused on design, delivery and immunogenicity of alphavirus-based vaccines against SARS-CoV-2, chikungunya, HIV (EHVA project), Ebola and HBV (IP-Cure-B project) • writing scientific articles and grant applications, presenting research at conferences • planning the clinical trial and handling all aspects of moving the product into production • collaborating and communicating with partners from other laboratories • supervising students
• conducting research focused on the influence of vaccine antigens and adjuvants on innate and adaptive immunity in non-human primate model
• development of alphavirus vaccine vectors for infectious diseases
• development and evaluation of a VLP vaccine against influenza
• biodistribution of a VLP vaccine platform in a mouse model Supervisor: David Laurin, PhD
• evaluation of immunogenicity and efficacy of an influenza VLP vaccine in animal model Supervisor: Bénédicte Lambrecht, PhD
• evaluation of an influenza VLP vaccine in respect of its safety and immunogenicity in vitro in human peripheral blood mononuclear cells Supervisor: David Laurin, PhD
Evaluation of the influenza VLP vaccine in respect of its safety and immunogenicity in vitro in human peripheral blood mononuclear cells. Supervisor: David Laurin, PhD